Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248156 · ClinicalTrials.gov registry record
The Maintenance of Human Atrial Fibrillation
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 5
- Enrollment target
NCT01248156: Completed study, sponsored by University of California, San Diego.
NCT01248156 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01248156 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Atrial fibrillation (AF) is the most prevalent heart rhythm disorder in the United States, affecting 2.5 million individuals in whom it may cause stroke, palpitations, heart failure, and even death. Unfortunately, therapy for AF is limited. Anti-arrhythmic or rate-controlling drugs are poorly tolerated, with frequent side effects and do not reduce stroke risk. Ablation is an emerging, minimally invasive therapy that has attracted considerable attention because it may eliminate AF. Unfortunately, AF ablation is technically challenging, with a success of only 50-70% (versus \>90% for other arrhythmias) and serious risks. A major cause of these limitations is that the mechanisms for human AF are not known and thus ablation cannot be directed to them. As a result, AF ablation is empiric and results in extensive destruction of the atrium. This project will perform research to better understand AF and determine if abnormal activity in small regions or more widespread regions of the heart cause AF. By performing these studies in patients during clinical procedures, this project may lead to a paradigm shift in the understanding and treatment of AF.
Primary Outcome
recurrence of AF measured using clinical follow-up with implanted devices in all patients who consent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-06 |
What the finished NCT01248156 record still lists
NCT01248156 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01248156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01248156 about?
NCT01248156 is a clinical study titled "The Maintenance of Human Atrial Fibrillation". Atrial fibrillation (AF) is the most prevalent heart rhythm disorder in the United States, affecting 2.5 million individuals in whom it may cause stroke, palpitations, heart failure, and even death. Unfortunately, therapy for AF is limited. Anti-arrhythmic or rate-controlling drugs are poorly tolera...
What is the current status of trial NCT01248156?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2010-12. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01248156?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia